← Back to Patent Explorer
US4942129A Expired / Lapsed US ⏱️ 0.0 years remaining

Multiple membrane microencapsulation

Assignee: Queen's University
•
Filing: 1988-07-12
•
Granted: 1990-07-17
•
Expires: 2008-07-12
📄 Original PDF 🌐 Google Patents 🔄 Sync Now

Abstract

Abstract Living tissues, such as hybridoma cells or insect cells suspended in a water soluble gelling agent, are microencapsulated in a double polymeric membrane microcapsule. The inner membrane is of a high molecular weight cut-off to permit outward diffusion of the gelling agent and also expansion of the microcapsule before formation of the outer membrane which is a relatively lower molecular weight cut-off. The living cells in the dual membrane microcapsule may be grown to an intracapsular density which is significantly higher than that which can be achieved by using single-membrane capsules. The recovery of intracapsular protein product (produced by the encapsulated cells) is also significantly higher and the loss of product through the membrane wall markedly lower for the dual membrane capsule than for the single membrane capsule.

Inventors

  • 👤 Matheus F. A. Goosen
  • 👤 Glenn A. King
  • 👤 Andrew J. Daugulis
  • 👤 Peter Faulkner

Bibliographic Details

Application Number —
Jurisdiction US
Data Source google_patents
Last Synchronized 2026-10-23 12:10
CPC Classifications
A; A61; A61K; A61K9/00; A61K9/48; A61K9/50; A61K9/5073; A61K9/5089; C; C07; C07K; C07K16/00; C12; C12N; C12N11/00; C12N11/02; C12N11/04; C12N5/00; C12N5/0012; C12N5/06; C12N5/0601; C12N5/10; C12N5/12; C12N2533/00; C12N2533/70; C12N2533/72

Claims Analysis

Total Claims: 26
Claim 1
Independent Claim 168 words
A biocompatible microcapsule, having a diameter of about 400-500 m, comprising: a macromolecular core material comprising living tissue surrounded by a first biocompatible highly permeable hydrogel membrane consisting of ionically interacted biocompatible materials, having a molecular weight cut-off of about 200-400× 10 3 ; and said first membrane being interacted with ionically interacted biocompatible materials to form a second relatively less permeable hydrogel membrane having a molecular cut-off of about 40-80×10 3 ; said first membrane being sufficiently permeable to permit diffusion therethrough of that portion of a water soluble cross-linkable gelling agent used to suspend said living tissue and having a molecular weight of less than 200-400 ×10 3 , and permitting expansion of said microcapsule towards an equilibrium state; and said second membrane being sufficiently permeable to permit nutrients to flow from a medium in which said microcapsule is placed into said microcapsule to sustain said living tissue, and sufficiently impermeable to retain said living tissue and any high molecular weight product thereof within the microcapsule.
Claim 2
Dependent Claim 168 words
A biocompatible microcapsule, having a diameter of about 400-500 m, comprising: a macromolecular core material comprising living tissue surrounded by a first biocompatible highly permeable hydrogel membrane consisting of ionically interacted biocompatible materials, having a molecular weight cut-off of about 200-400× 10 3 ; and said first membrane being interacted with ionically interacted biocompatible materials to form a second relatively less permeable hydrogel membrane having a molecular cut-off of about 40-80×10 3 ; said first membrane being sufficiently permeable to permit diffusion therethrough of that portion of a water soluble cross-linkable gelling agent used to suspend said living tissue and having a molecular weight of less than 200-400 ×10 3 , and permitting expansion of said microcapsule towards an equilibrium state; and said second membrane being sufficiently permeable to permit nutrients to flow from a medium in which said microcapsule is placed into said microcapsule to sustain said living tissue, and sufficiently impermeable to retain said living tissue and any high molecular weight product thereof within the microcapsule.
Claim 3
Dependent Claim 26 words
A microcapsule as claimed in claim 1 wherein said living tissue is selected from islets of langerhans, liver cells, blood cells, plant cells and hydridoma cells.
Claim 4
Dependent Claim 33 words
A microcapsule as claimed in claim 1 wherein said first and second membranes are formed by reaction between a polymeric material having positively charged groups and a polymeric material having negatively charged groups.
Claim 5
Dependent Claim 27 words
A microcapsule as claimed in claim 3 wherein said positively charged polymeric material contains amino groups and the negatively charged polymeric material contains carboxyl or hydroxyl group.
Claim 6
Dependent Claim 24 words
A microcapsule as claimed in claim 4 wherein said first and second membranes are formed from an alkali metal alginate and a polyamino acid.
Claim 7
Dependent Claim 21 words
A microcapsule as claimed in claim 5 wherein said alkali metal alginate is sodium alginate and said polyamino acid is poly-l-lysine.
Claim 8
Independent Claim 236 words
A method of encapsulating living tissue within two semi permeable hydrogel membranes which comprises: (a) mixing said living tissue with an aqueous solution of water soluble polymeric material which can be reversibly gelled and which has free acid groups. (b) forming said mixture into droplets and gelling said droplets in a hardening agent; (c) forming a first biocompatible highly permeable hydrogel membrane about said first gelled droplets to produce a first microcapsule by reaction with a polymer containing free amino groups; said first membrane having a molecular weight cut-off of 200-400×10 3 ; (d) suspending said first microcapsule in a medium which reliquifies said water soluble polymeric material; (e) incubating said first microcapsule in an aqueous medium for sufficient time to allow at least one third of that portion of said water soluble polymeric material having a molecular weight of less than 200-400×10 3 to diffuse out of said microcapsule, and to allow said microcapsule to expand towards an equilibrium state; (f) reacting said incubated first microcapsule with a polymer containing positively charged groups to thereby form an interacted relatively less permeable hydrogel membrane having a molecular weight cut-off of 40-80×10 3 ; and (g) incubating said living tissue within said interacted microcapsule in a nutrient medium; said interacted membrane being sufficiently permeable to permit passage of nutrients and sufficiently impermeable to retain said tissue and any high molecular weight products thereof within said second microcapsule.
Claim 9
Independent Claim 236 words
A method of encapsulating living tissue within two semi permeable hydrogel membranes which comprises: (a) mixing said living tissue with an aqueous solution of water soluble polymeric material which can be reversibly gelled and which has free acid groups. (b) forming said mixture into droplets and gelling said droplets in a hardening agent; (c) forming a first biocompatible highly permeable hydrogel membrane about said first gelled droplets to produce a first microcapsule by reaction with a polymer containing free amino groups; said first membrane having a molecular weight cut-off of 200-400×10 3 ; (d) suspending said first microcapsule in a medium which reliquifies said water soluble polymeric material; (e) incubating said first microcapsule in an aqueous medium for sufficient time to allow at least one third of that portion of said water soluble polymeric material having a molecular weight of less than 200-400×10 3 to diffuse out of said microcapsule, and to allow said microcapsule to expand towards an equilibrium state; (f) reacting said incubated first microcapsule with a polymer containing positively charged groups to thereby form an interacted relatively less permeable hydrogel membrane having a molecular weight cut-off of 40-80×10 3 ; and (g) incubating said living tissue within said interacted microcapsule in a nutrient medium; said interacted membrane being sufficiently permeable to permit passage of nutrients and sufficiently impermeable to retain said tissue and any high molecular weight products thereof within said second microcapsule.
Claim 10
Dependent Claim 27 words
The method of claim 7 wherein said living tissue is selected from islets of Langenhans, liver cells, blood cells and hybridoma cells, insect cells and plant cells.
Claim 11
Dependent Claim 15 words
The method of claim 7 wherein said water soluble polymeric material is a polysaccharide gum.
Claim 12
Dependent Claim 14 words
The method of claim 9 wherein said polysaccharide gum is an alkali metal alginate.
Claim 13
Dependent Claim 11 words
The method of claim 10 wherein said alginate is sodium alginate.
Claim 14
Dependent Claim 15 words
The method of claim 7 wherein said polymer containing amino groups is a polyamino acid.
Claim 15
Dependent Claim 11 words
The method of claim 12 wherein said polyamino acid is poly-l-lysine.
Claim 16
Dependent Claim 19 words
A microcapsule as claimed in claim 2 wherein said second membrane is a separate membrane over said first membrane.
Claim 17
Dependent Claim 17 words
A microcapsule as claimed in claim 1 wherein said second membrane is integral with said first membrane.
Claim 18
Dependent Claim 19 words
A microcapsule as claimed in claim 2 wherein said insect cell is a temperature sensitive baculovirus infected insect cell.
Claim 19
Dependent Claim 14 words
A microcapsule as claimed in claim 16 wherein said insect cell is spodoptera frugipada.
Claim 20
Dependent Claim 17 words
A microcapsule as claimed in claim 17 wherein said baculovirus is ts-10 Autographa californica Nuclear polyhedrosis Virus.
Claim 21
Dependent Claim 17 words
The method of claim 8 wherein said insect cell is a temperature sensitive baculovirus infected insect cell.
Claim 22
Dependent Claim 14 words
The method as claimed in claim 19 wherein said insect cell is spodoptera frugipada.
Claim 23
Dependent Claim 15 words
The method of claim 20 wherein said baculovirus is ts-10 Autographa californica Nuclear polyhedrosis virus.
Claim 24
Dependent Claim 23 words
The method of claim 21 wherein said water soluble polymeric material is sodium alginate, having an intracapsular concentration of less than 0.75% (w/v).
Claim 25
Dependent Claim 21 words
The method of claim 21 wherein said watersoluble polymeric material is sodium alginate having a viscosity in the range 10-20 cps.
Claim 26
Dependent Claim 16 words
The method of claim 23 wherein said sodium alginate has a viscosity of about 15 cps.

References Cited (Backward Citations)

US4352883A Cited
US4391909A Cited
US4409331A Cited
US4251387A Cited
US4257884A Cited
US4407957A Cited
US4495288A Cited
US4582799A Cited
US4803168A Cited
US4778749A Cited

USPTO Annuity & Maintenance Windows

Annuity Stage Window Opens Payment Deadline Surcharge Period Until Estimated Fee Status
3.5 Years (Year 4) 1993-07-16 1994-01-15 1994-07-17 $2000.00 Window Closed / Lapsed
7.5 Years (Year 8) 1997-07-16 1998-01-15 1998-07-17 $3760.00 Window Closed / Lapsed
11.5 Years (Year 12) 2001-07-16 2002-01-15 2002-07-17 $7700.00 Window Closed / Lapsed

Assigned Categories & Tags

No categories assigned to this patent yet.

Assign Category Tag